More articles from Original Article

You have access
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
Jingjing Wu, Fenghua Gao, Wenhua Wang, Xudong Zhang, Meng Dong, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Linan Zhu, Mengjie Ding, Songtao Niu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqian Yan, Hui Yu, Xiaolong Wu, Zhiyuan Zhou, Jieming Zhang and Mingzhi Zhang

Cancer Biology & Medicine July 2022, 19 (7) 1089-1099; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0026
You have access
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang

Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
You have access
Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi

Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193
You have access
MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li

Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296
You have access
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu

Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
You have access
Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang

Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598
You have access
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam

Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667
You have access
The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu

Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011
You have access
EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang

Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371
You have access
JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ
Zilu Zhang, Chenjing Ye, Jia Liu, Wenbin Xu, Chao Wu, Qing Yu, Xiaoguang Xu, Xinyi Zeng, Huizi Jin, Yingli Wu and Hua Yan

Cancer Biology & Medicine May 2022, 19 (5) 651-668; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0473

Main menu

User menu

Search

More articles from Original Article

Pages

Navigate

More Information

For Authors

Journal Services